中华流行病学杂志
中華流行病學雜誌
중화류행병학잡지
CHINESE JOURNAL OF EPIDEMIOLOGY
2012年
6期
554-557
,共4页
李倩%杜佳%关鹏%杜君%曲春枫%代敏
李倩%杜佳%關鵬%杜君%麯春楓%代敏
리천%두가%관붕%두군%곡춘풍%대민
肝肿瘤%发病率%死亡率%患病数
肝腫瘤%髮病率%死亡率%患病數
간종류%발병솔%사망솔%환병수
Liver neoplasm%Incidence%Mortality%Prevalence
目的 估计中国2008年肝癌发病、死亡和患病情况,并预测未来20年发病数和死亡数.方法 根据中国36个肿瘤登记点的数据以及全国第三次死因调查(2004-2005年)的结果,估计中国2008年肝癌发病、死亡和患病情况,并预测2010、2015、2020、2025和2030年肝癌的发病数和死亡数.结果 2008年中国肝癌新发病例数约为40.2万(占所有恶性肿瘤发病例数的14.3%),死亡病例数约为37.2万(占所有恶性肿瘤死亡例数的19.0%).世界人口标化发病率和标化死亡率分别为25.7/10万(居所有恶性肿瘤第3位)和23.7/10万(居所有恶性肿瘤第2位).2008年中国15岁以上人群肝癌5年患病数约为29.6万,占所有恶性肿瘤5年患病数的6.4%,5年患病率为27.7/10万,排在所有恶性肿瘤的第6位.在肝癌新发病例中72.8%为男性,男女性别比为2.7:1;死亡病例中74.3%为男性,男女性别比为2.9:1.在任何年龄段,男性肝癌的发病率和死亡率均高于女性.40岁以上人群,尤其是男性,是肝癌的高发人群;未来20年,中国肝癌的发病数和死亡数均将呈现上升趋势.结论 肝癌是中国主要癌症之一,其死亡率仅次于肺癌,发病和死亡情况在未来20年将越来越严峻,40岁以上男性是肝癌重点防控人群.
目的 估計中國2008年肝癌髮病、死亡和患病情況,併預測未來20年髮病數和死亡數.方法 根據中國36箇腫瘤登記點的數據以及全國第三次死因調查(2004-2005年)的結果,估計中國2008年肝癌髮病、死亡和患病情況,併預測2010、2015、2020、2025和2030年肝癌的髮病數和死亡數.結果 2008年中國肝癌新髮病例數約為40.2萬(佔所有噁性腫瘤髮病例數的14.3%),死亡病例數約為37.2萬(佔所有噁性腫瘤死亡例數的19.0%).世界人口標化髮病率和標化死亡率分彆為25.7/10萬(居所有噁性腫瘤第3位)和23.7/10萬(居所有噁性腫瘤第2位).2008年中國15歲以上人群肝癌5年患病數約為29.6萬,佔所有噁性腫瘤5年患病數的6.4%,5年患病率為27.7/10萬,排在所有噁性腫瘤的第6位.在肝癌新髮病例中72.8%為男性,男女性彆比為2.7:1;死亡病例中74.3%為男性,男女性彆比為2.9:1.在任何年齡段,男性肝癌的髮病率和死亡率均高于女性.40歲以上人群,尤其是男性,是肝癌的高髮人群;未來20年,中國肝癌的髮病數和死亡數均將呈現上升趨勢.結論 肝癌是中國主要癌癥之一,其死亡率僅次于肺癌,髮病和死亡情況在未來20年將越來越嚴峻,40歲以上男性是肝癌重點防控人群.
목적 고계중국2008년간암발병、사망화환병정황,병예측미래20년발병수화사망수.방법 근거중국36개종류등기점적수거이급전국제삼차사인조사(2004-2005년)적결과,고계중국2008년간암발병、사망화환병정황,병예측2010、2015、2020、2025화2030년간암적발병수화사망수.결과 2008년중국간암신발병례수약위40.2만(점소유악성종류발병례수적14.3%),사망병례수약위37.2만(점소유악성종류사망례수적19.0%).세계인구표화발병솔화표화사망솔분별위25.7/10만(거소유악성종류제3위)화23.7/10만(거소유악성종류제2위).2008년중국15세이상인군간암5년환병수약위29.6만,점소유악성종류5년환병수적6.4%,5년환병솔위27.7/10만,배재소유악성종류적제6위.재간암신발병례중72.8%위남성,남녀성별비위2.7:1;사망병례중74.3%위남성,남녀성별비위2.9:1.재임하년령단,남성간암적발병솔화사망솔균고우녀성.40세이상인군,우기시남성,시간암적고발인군;미래20년,중국간암적발병수화사망수균장정현상승추세.결론 간암시중국주요암증지일,기사망솔부차우폐암,발병화사망정황재미래20년장월래월엄준,40세이상남성시간암중점방공인군.
Objective To estimate the incidence,mortality and 5-year prevalence rates of liver cancer in 2008,China.Methods Data from both 36 cancer registries and the Third National Death Survey in China (2004-2005) were used to estimate the incidence,mortality and 5-year prevalence of liver cancer in 2008 in the country by using the mathematical models to predict the liver cancer incidence and mortality in the next 20 years.Results In 2008,the incident cases of liver cancer was 402 208 ( 14.3% of the total cancers) and the number of deaths from liver cancer was 372 079 ( 19.0% of the total cancers).The incidence rate was 25.7/100 000,ranking the third among all cancers.The mortality rate was 23.7/100 000,ranking the second among all the cancers.The 5-year prevalence of liver cancer was 296 082 (6.4% of the total cancers) with the proportion as 27.7/100 000,ranking the sixth among all the cancers.72.8% of the liver cancer cases appeared in men and the sex ratio of male to female was 2.7:1.In terms of deaths due to liver cancer,74.3% of them occurred in men,with sex ratio of male to female as 2.9:1.At any age group,the incidence and mortality of liver cancer among males were higher than those of females.Liver cancer happened more frequently among people older than 40 years of age,particularly among males.Data under our prediction showed that the incidence and mortality of liver cancer in China would gradually increase in the next 20 years.Conclusion Liver cancer is one of the most important public health issues in China.Both incidence and mortality of liver cancer have been increasing in China.The key populations for liver cancer prevention and control programs should be those who were older than 40-year-old,particularly on men.